CoChat

Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule

Open access
Voltolini, S., Modena, P., Minale, P., Bignardi, D., Troise, C., Puccinelli, P., Parmiani, S. · 2001 · Allergologia et Immunopathologia
Cited by 61

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

sublingual immunotherapy has been recognised as safe and effective but it is still poorly documented in tree pollen allergy. Allergy to alder, birch and hazel is important in Northern European countries but its clinical relevance is increasing in Southern Europe thirty patients, selected and observed for one pollen season, were randomised to receive placebo (15 patients) or active treatment (15 patients). Twenty-seven patients completed the first year and 24 of them were treated with active therapy during the second year of the study in comparison to a parallel group of ten patients treated only with drugs. Symptom and drug scores during each pollen season, birch-specific IgE, changes in skin test reactivity, changes in specific Nasal Provocation Test and the daily average pollen count for the relevant trees were considered for the assessment of the efficacy of the treatment both active and placebo group showed a statistically significant improvement in scores in comparison to the previous year, under a lower allergenic pressure. The improvement was higher in the active group (76.04 % reduction of drugs) but not significantly different from that registered in the placebo group (37.05 % reduction). In the open phase of the study, treated patients showed significantly better scores in comparison to the control group. No significant changes in skin reactivity, specific IgE and Nasal Provocation Test were registered. SLIT tolerance was very good our data show a better but not statistically significant clinical outcome for patients actively treated with SLIT, but the placebo effect and the year-by-year variability of the environmental allergenic load in our small-size pilot study do not allow for a conclusive statement about the efficacy of this form of therapy la inmunoterapia sublingual ha sido reconocida como segura y eficaz pero está aún pobremente documentada sobre alergia al polen de árboles. La alergia al aliso, abedul y avellano es importante en los países del norte de Europa, pero su relevancia clínica está aumentando en el sur de Europa 30 pacientes seleccionados y observados a lo largo de una época de polinización, fueron aleatorizados para recibir placebo (15 pacientes) o tratamiento activo (15 pacientes). Completaron el primer año 27 pacientes y 24 de ellos fueron tratados con inmunoterapia activa durante el segundo año del estudio, comparándose con un grupo paralelo tratado solamente con medicamentos. El registro de síntomas y medicamentos durante cada época de polinización, IgE específica al aliso, cambios en la reactividad de la piel, cambio en la prueba de provocación nasal específica y el recuento diario de pólenes de los árboles relevantes fueron considerados para evaluar la eficacia del tratamiento tanto el grupo activo como el placebo mostraron una mejora estadísticamente significativa en los registros, en comparación al año anterior, bajo una menor presión alergénica. La mejoría fue mayor en el grupo activo (76,04 % de reducción de medicamentos) que en el placebo (37,05 % de reducción). En la fase abierta del estudio, los pacientes tratados mostraron una puntuación significativamente mejor que el grupo control. No se registraron cambios significativos en la reactividad de la piel, IgE específica y prueba de provocación nasal específica. La tolerancia del SLIT fue muy buena nuestra información muestra un mejor, que no estadísticamente significativo, resultado clínico, en los pacientes tratados con el tratamiento SLIT activo, pero el efecto placebo y la variabilidad de año en año de la carga ambiental alergénica en nuestro pequeño ensayo piloto, no permiten realizar una afirmación concluyente sobre la eficacia de este tipo de terapia

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0301-0546(01)79041-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Oral immunotherapy in birch pollen hay fever

    Taudorf, E., Laursen, L. C., Lanner, Å., Björksten, B., Dreborg, S., Søborg, M., & Weeke, B. (1987) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(87)90124-2 · Cited by 129 · cited 2×

    “In the abundant literature on Specif ic Immunotherapy, studies on hyposensitisation w ith extracts of pollen of Betulaceae/Corylaceae (birch and hazel) are uncommon and only a few have been run w ith non-injective therapies (16-20).”

Show all 1 references

Cited by

See all 61

Metadata

Authors
Voltolini, S., Modena, P., Minale, P., Bignardi, D., Troise, C., Puccinelli, P., & Parmiani, S.
Venue
Allergologia et Immunopathologia
Published
2001-01
Volume
29
Issue
4
Pages
103-110
ISSN
0301-0546 (ISSN-L)
OpenAlex
W2030014293
Cited by
61
References
1
FWCI
2.18
Type
journal article
Language
es
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. https://app.cochat.ai/papers/10.1016/s0301-0546(01)79041-6
The paper
Voltolini, S., Modena, P., Minale, P., Bignardi, D., Troise, C., Puccinelli, P., & Parmiani, S. (2001). Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergologia et Immunopathologia. https://doi.org/10.1016/s0301-0546(01)79041-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.